Jiangsu CoWin Biotech Co., Ltd. (SHA:688426)
China
· Delayed Price · Currency is CNY 20.40
+0.55 (2.77%)
Apr 29, 2026, 4:00 PM EDT
Jiangsu CoWin Biotech Market Cap
Jiangsu CoWin Biotech has a market cap or net worth of 2.24 billion as of April 29, 2026. Its market cap has increased by 6.25% in one year.
Market Cap
2.24B
Enterprise Value
1.68B
Revenue
193.52M
Ranking
n/a
PE Ratio
n/a
Stock Price
20.40
Market Cap Chart
Since October 25, 2022, Jiangsu CoWin Biotech's market cap has decreased from 4.06B to 2.24B, a decrease of -44.81%. That is a compound annual growth rate of -15.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 2.18B | -16.70% |
| Dec 31, 2025 | 2.62B | -17.62% |
| Dec 31, 2024 | 3.18B | -7.26% |
| Dec 29, 2023 | 3.43B | 3.44% |
| Dec 30, 2022 | 3.31B | -18.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Gdk Biological Technology | 2.14B |
| Guiyang Xintian Pharmaceutical | 2.28B |
| Zhejiang East Asia Pharmaceutical | 2.37B |
| Shanghai Hile Bio-Technology | 2.51B |
| Shanghai Universal Biotech | 2.60B |
| Suzhou Fushilai Pharmaceutical | 2.61B |
| Cabio Biotech (Wuhan) | 2.65B |
| Jilin Jian Yisheng Pharmaceutical | 2.70B |